FDA Inspection 1019906 — Wakunaga Pharmaceutical Co.,ltd. Hiroshima
The FDA completed an inspection of Wakunaga Pharmaceutical Co.,ltd. Hiroshima on July 25, 2017 in Akitakata. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Food/Cosmetics.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- July 25, 2017
- Fiscal Year
- 2017
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Akitakata (Japan)
Citations
| ID | CFR | Description |
|---|---|---|
| 15450 | 21 CFR 111.15(f)(3) | Plumbing - source of contamination |
| 15560 | 21 CFR 111.260(k)(2) | Batch record - label |